These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 35262424)

  • 41. Comprehensive Review of Tenecteplase for Thrombolysis in Acute Ischemic Stroke.
    Wang L; Hao M; Wu N; Wu S; Fisher M; Xiong Y
    J Am Heart Assoc; 2024 May; 13(9):e031692. PubMed ID: 38686848
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial.
    Menon BK; Buck BH; Singh N; Deschaintre Y; Almekhlafi MA; Coutts SB; Thirunavukkarasu S; Khosravani H; Appireddy R; Moreau F; Gubitz G; Tkach A; Catanese L; Dowlatshahi D; Medvedev G; Mandzia J; Pikula A; Shankar J; Williams H; Field TS; Manosalva A; Siddiqui M; Zafar A; Imoukhuede O; Hunter G; Demchuk AM; Mishra S; Gioia LC; Jalini S; Cayer C; Phillips S; Elamin E; Shoamanesh A; Subramaniam S; Kate M; Jacquin G; Camden MC; Benali F; Alhabli I; Bala F; Horn M; Stotts G; Hill MD; Gladstone DJ; Poppe A; Sehgal A; Zhang Q; Lethebe BC; Doram C; Ademola A; Shamy M; Kenney C; Sajobi TT; Swartz RH;
    Lancet; 2022 Jul; 400(10347):161-169. PubMed ID: 35779553
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tenecteplase versus alteplase in stroke thrombolysis: An individual patient data meta-analysis of randomized controlled trials.
    Huang X; MacIsaac R; Thompson JL; Levin B; Buchsbaum R; Haley EC; Levi C; Campbell B; Bladin C; Parsons M; Muir KW
    Int J Stroke; 2016 Jul; 11(5):534-43. PubMed ID: 27048693
    [TBL] [Abstract][Full Text] [Related]  

  • 44. European Stroke Organisation (ESO) expedited recommendation on tenecteplase for acute ischaemic stroke.
    Alamowitch S; Turc G; Palaiodimou L; Bivard A; Cameron A; De Marchis GM; Fromm A; Kõrv J; Roaldsen MB; Katsanos AH; Tsivgoulis G
    Eur Stroke J; 2023 Mar; 8(1):8-54. PubMed ID: 37021186
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tenecteplase for the treatment of acute ischemic stroke: A review of completed and ongoing randomized controlled trials.
    Coutts SB; Berge E; Campbell BC; Muir KW; Parsons MW
    Int J Stroke; 2018 Dec; 13(9):885-892. PubMed ID: 30035698
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Thrombolysis with Tenecteplase in a stroke with a long time window after onset of symptoms. Report of one case].
    Montecinos C; Angel MJ; Navia V
    Rev Med Chil; 2021 Jan; 149(1):128-131. PubMed ID: 34106144
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tenecteplase, 0.4 mg/kg, in Moderate and Severe Acute Ischemic Stroke: A Pooled Analysis of NOR-TEST and NOR-TEST 2A.
    Novotny V; Kvistad CE; Naess H; Logallo N; Fromm A; Khanevski AN; Thomassen L
    J Am Heart Assoc; 2023 Oct; 12(20):e030320. PubMed ID: 37830342
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improving neurological outcome for acute basilar artery occlusion with sufficient recanalization after thrombectomy by intraarterial tenecteplase (INSIST-IT): Rationale and design.
    Liu L; Li W; Qiu J; Nguyen TN; Wei M; Wang F; Li D; Shi HZ; Wang SC; Chen HS
    Eur Stroke J; 2023 Jun; 8(2):591-597. PubMed ID: 37231688
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
    Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
    JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Switching to Tenecteplase for Stroke Thrombolysis: Real-World Experience and Outcomes in a Regional Stroke Network.
    Mahawish K; Gommans J; Kleinig T; Lallu B; Tyson A; Ranta A
    Stroke; 2021 Oct; 52(10):e590-e593. PubMed ID: 34465202
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical outcomes and safety profile of Tenecteplase in wake-up stroke.
    Ahmed HK; Logallo N; Thomassen L; Novotny V; Mathisen SM; Kurz MW
    Acta Neurol Scand; 2020 Nov; 142(5):475-479. PubMed ID: 32511749
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tenecteplase versus alteplase after acute ischemic stroke at high age.
    Thommessen B; Næss H; Logallo N; Kvistad CE; Waje-Andreassen U; Ihle-Hansen H; Ihle-Hansen H; Thomassen L; Morten Rønning O
    Int J Stroke; 2021 Apr; 16(3):295-299. PubMed ID: 32631157
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Different doses of tenecteplase vs alteplase in thrombolysis therapy of acute ischemic stroke: evidence from randomized controlled trials.
    Xu N; Chen Z; Zhao C; Xue T; Wu X; Sun X; Wang Z
    Drug Des Devel Ther; 2018; 12():2071-2084. PubMed ID: 30013325
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Moving From Alteplase to Tenecteplase for Acute Ischemic Stroke: Mayo Clinic Experience.
    Koriesh A; Liu M; Brinjikji W; Klaas J; Nasr D; Keser Z
    Neurologist; 2024 Jan; 29(1):50-53. PubMed ID: 37839078
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quality of Life After Intravenous Thrombolysis for Acute Ischemic Stroke: Results From the AcT Randomized Controlled Trial.
    Sajobi TT; Arimoro OI; Ademola A; Singh N; Bala F; Almekhlafi MA; Deschaintre Y; Coutts SB; Thirunavukkarasu S; Khosravani H; Appireddy R; Moreau F; Gubitz GJ; Tkach A; Catanese L; Dowlatshahi D; Medvedev G; Mandzia J; Pikula A; Shankar JS; Williams H; Field TS; Manosalva A; Siddiqui M; Zafar A; Imoukhuede O; Hunter G; Demchuk AM; Mishra SM; Gioia LC; Jalini S; Cayer C; Phillips SJ; Elamin E; Shoamanesh A; Subramaniam S; Kate MP; Jacquin G; Camden MC; Benali F; Alhabli I; Horn M; Stotts G; Hill MD; Gladstone DJ; Poppe AY; Sehgal A; Zhang Q; Lethebe B; Doram C; Shamy M; Kenney C; Buck BH; Swartz RH; Menon BK
    Stroke; 2024 Mar; 55(3):524-531. PubMed ID: 38275116
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thrombolysis for acute ischemic stroke by tenecteplase in the emergency department of a Moroccan hospital.
    Belkouch A; Jidane S; Chouaib N; Elbouti A; Nebhani T; Sirbou R; Bakkali H; Belyamani L
    Pan Afr Med J; 2015; 21():37. PubMed ID: 26405473
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety and Efficacy of Tenecteplase in Older Patients With Large Vessel Occlusion: A Pooled Analysis of the EXTEND-IA TNK Trials.
    Yogendrakumar V; Churilov L; Mitchell PJ; Kleinig TJ; Yassi N; Thijs V; Wu TY; Shah DG; Ng FC; Dewey HM; Wijeratne T; Yan B; Desmond PM; Parsons MW; Donnan GA; Davis SM; Campbell BCV;
    Neurology; 2022 Mar; 98(12):e1292-e1301. PubMed ID: 35017305
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Extending the time window for intravenous thrombolysis in acute ischemic stroke using magnetic resonance imaging-based patient selection.
    Ringleb P; Bendszus M; Bluhmki E; Donnan G; Eschenfelder C; Fatar M; Kessler C; Molina C; Leys D; Muddegowda G; Poli S; Schellinger P; Schwab S; Serena J; Toni D; Wahlgren N; Hacke W;
    Int J Stroke; 2019 Jul; 14(5):483-490. PubMed ID: 30947642
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of pharmacokinetic properties of alteplase and tenecteplase. The future of thrombolysis in acute ischemic stroke.
    Marè A; Lorenzut S; Janes F; Gentile C; Marinig R; Tereshko Y; Gigli GL; Valente M; Merlino G
    Expert Opin Drug Metab Toxicol; 2024; 20(1-2):25-36. PubMed ID: 38275111
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tenecteplase versus Alteplase before thrombectomy: A comprehensive evaluation of clinical and angiographic impact: Insights from the ETIS registry.
    Zarzour A; Batot C; Boisseau W; Cho TH; Guillon B; Richard S; Marnat G; Arquizan C; Lapergue B; Weisenburger Lile D;
    J Neuroradiol; 2024 Jun; 51(4):101189. PubMed ID: 38462131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.